Search for company
Explore more than 1.3 million company profiles from emerging markets

Ckd Bio Corp. (Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Quote Chart
Quote Summary
Last Price 26,900.00
Volume 69,730
Turnover 1,847,845,000
Index
Market Korea Stock Exchange
Ticker 63160
Market Cap Market Cap 140,673,254
52 Week High 31,500.00
52 Week Low 12,400.00
P/E -127.3
EPS -211.31
Dividend Yield
Bookvalue 121,788,820
Enterprise Value 140,608,690
Quote updated on May 28, 2015
Note: data in KRW Thousands.
Financials
Select Items to chart them. 2014 Y
Net sales revenue
Total Operating Revenue
Operating profit (EBIT)
EBITDA
Net Profit(Loss)
Total Assets 165,068,245
Total equity
Operating Profit Margin
Return on Sales (ROS)
Return on Equity (ROE)
Debt to equity
Quick ratio
Cash Ratio
Note: units in Thousands. Statement: Audited, Individual
Source: Korea Information Service (KIS), EMIS Company Database.
Company Description

Ckd Bio Corp. is engaged in manufacturing and distribution of pharmaceutical materials and medicines. The company distribute its products in markets including Asia, Africa, Middle East, Japan. Europe and America. Ckd Bio Corp. is based in Seoul with operating plants in Ansan and Chonan, South Korea. The company was incorporated in 2001 formerly known as Chong Kun Dang Pharmaceutical Co., Ltd.

More
Main Products

Medeicinal supplies, material madicine

Contact Information

Headquarters
8, Chungjeong-ro Seodaemun-gu Seoul
Seoul; Seoul; Map
Postal Code: 120756
Tel: 02-2194-0555
Fax: 02-2194-0556
Website: http://www.ckdbio.com

Full name: Ckd Bio Corp.

Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
Incorporation Date: 12-Nov-01

Basic Information
Total Employees:
()
Outstanding Shares:
: ()
Registered Capital:
()
Financial Auditors:
()
Key Executives
Non-Executive Independent Director
More
Ownership Details
Lee, Jang Han
19.1%
Other
Corporate Actions
EMIS Benchmark Score
EMIS DealWatch Deals
DealMonitor Deal Intents
EMIS DealWatch News
Financial Documents/Annual Reports
Competitors - Korea
KRW | USD | EUR
Analysis/Research

Receive our Global EMIS Insider

The Global EMIS Insider is a our monthly source of Emerging Markets Information Service (EMIS) functionality enhancements and new content releases in each of our countries worldwide.
First Name: *
Country: *
Last Name: * Company: *
Email: * Position: *
Security Code: *   * Indicates required field.

USE OF YOUR INFORMATION:
EMIS is part of the Euromoney Institutional Investor PLC group of companies. Click here for more details on our group's activities.
We will use the information you provide here to process your order/registration/request including communicating with you about it. If you are registering for a trial, you will receive a follow up email and/or call asking you about your trial. As part of the trial, you may also receive email updates and other features as specified for that product. We may monitor your use of our website(s). As an international group, we may transfer your data on a global basis. Subject to your choices below, we may also use your data for marketing purposes. By submitting your details, you will be indicating your consent to the use of your data as identified here. Further information is set out in our privacy policy on this site.

Please tick if you don't want to receive details of products, services and special offers from our group companies by:

Phone    Fax    Email    Mail

Please tick if you don't want to receive details of relevant products, services and special offers from selected companies outside our group

I have read and agree to the Terms and Conditions.

I have read and agree to the Privacy Policy.